A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
Clinical trial NCT06701721 · RECRUITING
Trial details
- NCT number
- NCT06701721
- Sponsor
- Therini Bio Pty Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2027-03-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.